Nov 15, 2020 | Wealth Management
Nearly $45 billion in net inflows rushed toward equity funds this week, reflecting the optimism from resolution in two events that have plagued the market all year – the elections and lack of vaccine. With both these risks out of the way, the markets have begun...
Nov 1, 2020 | Wealth Management
As the coronavirus soars across the country, charting a single-day record of 99,155 new cases on Friday and surpassing nine million cases nationwide, tracing the path of the pandemic in the United States is no longer simply challenging. It has become nearly...
Oct 18, 2020 | Wealth Management
In the last few days, Johnson & Johnson’s vaccine study was paused after a volunteer got sick and Eli Lilly & Co.’s antibody study was halted enrollment over a safety concern. AstraZeneca Plc’s vaccine has been on hold since early September. Only Pfizer still...
Oct 11, 2020 | Wealth Management
Last year, the yield curve inverted and sent chills down investors’ spines. Since then, we have indeed fallen into a recession, but one driven by the pandemic. Now, the yield curve is showing what else it can do. Currently, bear steepening has taken hold – which...
Sep 20, 2020 | Wealth Management
The Department of Labor (DOL) recently issued guidance allowing employers to add retirement funds into their 401K investment lineup that invest in private equity. Private-equity funds, which fall into the broader category of alternative investments, have only been...
Sep 6, 2020 | Wealth Management
US Debt levels hit a postwar record this week and the debt surpassed 100% of GDP for the April to June quarter. That would put the US in the company of a esoteric few – Japan, Italy and Greece. In the meantime, the Dow briefly topped 29000 before pulling back...
